Policy Perspective
COGR Testimony at NIH Hearings on March-in Rights
NIH has denied the request from Essential Inventions, Inc. to exercise march-in rights under The Bayh-Dole Act in connection with the pricing of Norvir, marketed by Abbott Laboratories for the treatment of patients with HIV/AIDS. The decision and related materials are available online.
Notification Letter for 45 CFR 46.118 Determinations for NSF Awards
COGR has been working with NSF staff to develop
Costing Issues
COGR provides an in-depth analysis of how universities address federal requirements for effort reporting related to compensation on federally funded research awards. Triggered by recent audit findings and heightened oversight, the paper explores the relevant federal guidance—principally OMB Circular A-21 and A-110—and highlights the inherent challenges universities face in accurately tracking and
COGR Meeting Report - February 2011
The COGR Meeting Report from February 2011 provides a detailed overview of the key issues and developments affecting research universities in the areas of costing policies, contracts and intellectual property, and research compliance and administration. The report emphasizes significant audit activities led by the Federal Office of Inspectors General, especially in regards to administrative and cl
